Strategic Advisory for Preclinical and Clinical Biotech Programs
I support biotech companies in the rigorous evaluation, prioritization, and strategic positioning of their development programs — providing a robust foundation for investment and development decisions.
With 18 years of experience in the biotech sector, I advise decision-makers at the interface of science, clinical development, regulatory strategy, and portfolio management.
My focus is on bringing clarity to complex clinical programs and translating scientific and clinical data into actionable, risk-adjusted strategic recommendations — objective, independent, and execution-oriented.
company data |
|
| employees: | <= 5 |
| legal form: | Einzelunternehmen |
| founding date: | 2026 |
| Mitglied im Cluster: | |
export countries: |
|
| worldwide | |
references: |
|
| Client identities are withheld for confidentiality and available upon request where appropriate. | |
products and services: |
|
|
Portfolio Strategy Commercial Valuation Corporate Development Licensing & Partnering R&D Prioritization Market & Competitive Assessment Pharmacoeconomics Strategic Market Assessment Game Theory |
|
contact information |
|
| street: | Am Bärnbichl 18 |
| ZIP code: | 82494 |
| city: | Krün |
| country: | Deutschland |
| phone: | +491719584431 |
| email: | engelbert.paschek@paschek-bioconsult.com |
| website: | https://www.paschek-bioconsult.com/ |
|
contact: |
Engelbert Paschek |
| function: | |
| phone: | +491719584431 |
| email: | engelbert.paschek@paschek-bioconsult.com |
-
competences and specialization
- Commercial Valuation
- Licensing &Partnering
- Portfolio Strategy
- R&D Prioritization
- Strategic Assessment